Researchers in London have reported a breakthrough in protein labeling that could lead to new tools to track disease, including cancer. Dubbed Bio-Orthogonal Cell line-specific Tagging of Glycoproteins (BOCTAG), the method developed by The Francis Crick Institute and Imperial College London uses Nobel Prize-winning click chemistry technology to identify proteins released by a specific type of cell, even when in complex environments with numerous other cell types.
The authors say BOCTAG will help in the identification of biomarkers—proteins that are highly valuable tools for a number of applications. In addition to helping to study disease, in the clinic biomarkers can diagnosis a disease from a blood or tissue sample, predict if a treatment will be effective in an individual, or see how much of a drug is reaching diseased cells.
Finding such biomarkers, however, is challenging. Scientists need to identify proteins that are uniquely made by diseased or cancerous cells but are not released by healthy cells.
“When you have a sample containing various cell lines, it is very difficult to identify the proteins that came from a specific line. Of course, in the laboratory, we can create experiments with only one type of cell, however these conditions do not mirror what happens in the body where complex interactions between cells could affect their behavior and so the proteins they release,” explains Ben Schumann, lead author and group leader at the Crick and Imperial College London.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
The new method is centered around adding chemical tags to sugar molecules which are added to cells. While all cells absorb the sugar, the researchers genetically modify the cell type they want to study, so that only this type adds the sugar to its proteins. When the cells make these proteins, they remain marked with the chemical tag, meaning that researchers can identify them.
The method uses bioorthogonal or ‘click’ chemistry which was awarded this year’s Nobel Prize in Chemistry. Stanford University’s Carbolyn Bertozzi, one of the prize recipients, is a co-author of this study. The chemical tag is selected so that it ‘clicks’ with another molecule that helps the researchers isolate the desired proteins or add a fluorescent tag to them.
The researchers showed that BOCTAG worked in cell cultures with multiple cell lines and also in mice, where the researchers successfully tagged proteins from particular cancer cells.
“In this study, we looked at proteins made by cancer cells, but our method could also be used in other fields including immunology or the study of infectious disease. It could also be used to better understand disease biology, including how tumor cells change as a result of complex interactions in the body,” says Anna Cioce, first author and postdoctoral training fellow at the Crick. “The next step for our team will be to continue developing this method and learning more about how cells produce different proteins depending on their environment,” adds Ben.
The findings were published recently in Nature Communications.